Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Shenzhen Edan Instruments Stages $146 Million ChiNext IPO

publication date: Apr 29, 2011

Shenzhen Edan Instruments, a medical device maker, has completed its IPO on the ChiNext exchange, raising 950 million RMB ($146 million). The company placed 25 million shares at 38 RMB each. Edan, which derives 65.5% of its revenues from exports, makes and sells a range of medical devices, including fetal monitoring, patient monitoring and electrocardiograph equipment. More details....

Stock Symbol: (SHE: 300206) Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.